Cargando…
Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
BACKGROUND: Atypical teratoid/rhabdoid tumors (ATRTs) are known to exhibit molecular and clinical heterogeneity even though SMARCB1 inactivation is the sole recurrent genetic event present in nearly all cases. Indeed, recent studies demonstrated 3 molecular subgroups of ATRTs that are genetically, e...
Autores principales: | Ho, Ben, Johann, Pascal D, Grabovska, Yura, De Dieu Andrianteranagna, Mamy Jean, Yao, Fupan, Frühwald, Michael, Hasselblatt, Martin, Bourdeaut, Franck, Williamson, Daniel, Huang, Annie, Kool, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229260/ https://www.ncbi.nlm.nih.gov/pubmed/31889194 http://dx.doi.org/10.1093/neuonc/noz235 |
Ejemplares similares
-
Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
por: Ho, Ben, et al.
Publicado: (2020) -
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
por: Zin, Francesca, et al.
Publicado: (2021) -
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
por: Holdhof, Dörthe, et al.
Publicado: (2020) -
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
por: Paassen, Irene, et al.
Publicado: (2023) -
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors
por: Blümel, Lena, et al.
Publicado: (2022)